Psav

Implications for Focal Therapy NIH Public Access Prostate

Implications for Focal Therapy NIH Public Access Prostate

13 Pages
652.2 KB
1,736
763

nih-pa author manuscript nih-pa author manuscript nih public access author manuscript j urol. author manuscript; available in pmc 2013 october 01. published in final edited form as: j urol. 2012 october ; 188(4): 1151–1156. doi:10.1016/j.juro.2012.06.010. updated results of magnetic resonance imaging guided partial prostate brachytherapy for favorable risk

Impact of PSA Levels on Second-round Screening for the

Impact of PSA Levels on Second-round Screening for the

8 Pages
155.5 KB
59,442
11,293

anticancer research 34: 6739-6746 (2014) impact of psa levels on second-round screening for the development of prostate cancer in men with low baseline psa levels (≤2.0 mg/ml) yasuhide kitagawa, kiyoshi sawada, satoko urata, kouji izumi, satoru ueno, yoshifumi kadono, hiroyuki konaka, atsushi mizokami and mikio namiki department of integrative

Applicazioni del PSA nella pratica clinica

Applicazioni del PSA nella pratica clinica

4 Pages
872 KB
15,648
4,068

rassegna applicazioni del psa nella pratica clinica ciro niro medico di medicina generale san severo (fg) responsabile nazionale dipartimento uro-andrologia aimef sull’utilizzo del psa come test di screening oncologico non vi sono ad ora evidenze scientifiche certe, tanto che anche i trial più recenti arrivano a conclusioni

0521 Prostate Cancer Screening (1)

0521 Prostate Cancer Screening (1)

35 Pages
483.2 KB
18,232
2,005

prostate cancer screening - medical clinical policy bulletins | aetna page 1 of 34 (https://www.aetna.com/) prostate cancer screening number: 0521 policy *please see amendment for pennsylvania medicaid at the end of this cpb. i. aetna considers prostate-specific antigen (psa) screening a medically necessary preventive service for men

The Association between Prostate-Specific Antigen Velocity

The Association between Prostate-Specific Antigen Velocity

14 Pages
1.3 MB
67,861
25,787

journal of clinical medicine article the association between prostate-specific antigen velocity (psav), value and acceleration, and of the free psa/total psa index or ratio, with prostate conditions maría-carmen flores-fraile 1, bárbara yolanda padilla-fernández 2 , sebastián valverde-martínez 1,3,4 , magaly marquez-sanchez 3 , maría-begoña garcía-cenador 1, maría-fernanda lorenzo-gómez 1,3,5

PSA velocity may not be of value in prostate cancer detection

PSA velocity may not be of value in prostate cancer detection

2 Pages
93.4 KB
79,136
20,575

asian journal of andrology (2011) 13, 616–617 ß 2011 aja, simm & sjtu. all rights reserved 1008-682x/11 $32.00 www.nature.com/aja research highlight psa velocity may not be of value in prostate cancer detection derrick johnston and martha k terris asian journal of andrology (2011) 13, 616–617; doi:10.1038/aja.2011.43; published online: